Modi government introduces messy maths in Supreme Court

The government has submitted an account of the corona vaccine made in the country to the Supreme Court. It is said that 85 million vaccine doses are prepared every month in the country. In the first three weeks of May, 3.6 crore vaccines have been given to the states.

Read more :

• Finance Ministry Recruitment 53 Post for Officer Registrar 2021

If we add the whole month's figure on this basis, it will be around five crores. In such an environment, the question arises whether the remaining crores. Where do crore vaccine doses go and why is there a shortage in the country?

Production of 25 million doses of corona vaccine per month in the country Allocation of 25 million doses to the states in three weeks Expect an allocation of 50 million doses during the month of May Where did the 25 million doses of corona vaccine go? 

Dosage Vaccination statistics in India is now a big mystery. In which government vaccination figures and vaccine production figures provided by vaccine manufacturers do not match. The discrepancy in this statistic is so great that this mystery cannot be swallowed up without proper disclosure. 

According to vaccine manufacturers, an average of 3 lakh vaccines are made daily in India, which does not yet include the Sputnik-Five vaccine. However, in the first three weeks of May, an average of 12.5 lakh doses were used daily for vaccination, according to the government's Co-Win portal. In addition, states are constantly complaining about the lack of vaccines.

Government affidavit

Serum Institute India India produces 25 million doses of Covishield every month. While India is producing 200 million doses of Biotech Kovasin. Production of Sputnik-3 will also be increased to 2.5 crore in July. The production of Sputnik-2 will also be increased to Rs 1.5 crore on a monthly basis from July.

Corona

In early May, the Center swore in the Supreme Court that Serum Institute India produces 25 million doses of Covishield a month. While India is producing 200 million doses of biotech covasin, which will increase to 2.5 million in July. The government also said that production of Sputnik-5 would be increased to 1.5 crore monthly doses from July.